Susquehanna International Group
PPBT

Susquehanna International Group’s Purple Biotech PPBT Stock Holding History

Susquehanna International Group’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$216K Buy
53,403
+6,426
+14% +$34.7K ﹤0.01% 11539
2025
Q4 		$309K Buy
+46,977
New +$341K ﹤0.01% 9880
2022
Q3 		– Sell
-57
Closed -$26.6K – 13917
2022
Q2 		$27K Sell
57
-65
-53% -$38.9K ﹤0.01% 12268
2022
Q1 		$97K Sell
122
-50
-29% -$32.3K ﹤0.01% 11937
2021
Q4 		$134K Buy
+172
New +$147K ﹤0.01% 11917
2021
Q1 		– Sell
-103
Closed -$96.1K – 12707
2020
Q4 		$79K Buy
+103
New +$86.8K ﹤0.01% 10600
2020
Q3 		– Sell
-14
Closed -$30K – 11011
2020
Q2 		$30K Sell
14
-63
-82% -$61.9K ﹤0.01% 9864
2020
Q1 		$47K Buy
+77
New +$94.4K ﹤0.01% 9709
2019
Q2 		– Sell
-6
Closed -$14K – 10692
2019
Q1 		$14K Sell
6
-42
-88% -$101K ﹤0.01% 8631
2018
Q4 		$63K Buy
48
+32
+200% +$80.5K ﹤0.01% 8402
2018
Q3 		$57K Buy
+16
New +$63.3K ﹤0.01% 8804
2018
Q1 		– Sell
-8
Closed -$38K – 9993
2017
Q4 		$38K Buy
+8
New +$35.7K ﹤0.01% 8978

Other funds holding PPBT

SP
SmartHarvest Portfolios Poulsbo, Washington $240M AUM
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Susquehanna International Group's PPBT Position: Q1 2026 in Review

Susquehanna International Group increased its Purple Biotech (PPBT) stake by 14% in Q1 2026, buying an estimated $34.7K and bringing the position to 53,403 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #11539.

Susquehanna International Group first reported a position in PPBT in Q4 2017 and has held it in 12 quarters since. The position peaked at $309K in Q4 2025. 15 funds tracked by Wall St. Rank hold PPBT as of Q1 2026.

  • Susquehanna International Group held 53,403 shares of Purple Biotech worth $216K as of Q1 2026.
  • Susquehanna International Group bought 6,426 Purple Biotech shares in Q1 2026, an estimated $34.7K.
  • Purple Biotech made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11539 holding.
  • Susquehanna International Group first reported a position in Purple Biotech in Q4 2017 and has held it in 12 quarters since.
  • Susquehanna International Group's Purple Biotech position peaked at $309K in Q4 2025.
  • 15 funds tracked by Wall St. Rank held Purple Biotech as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.